News | September 01, 2008

Health Discovery, Smart Personalized Medicine Agree to Develop Breast Cancer Test

September 2, 2008 - Health Discovery Corp. (HDC) said it has signed a licensing agreement with Smart Personalized Medicine LLC, founded by Richard Caruso, M.D., chairman and founder of Intergra Life Sciences) to work to develop a breast cancer prognostic test using HDC�s support vector machine (SVM) technology in collaboration with MD Anderson Cancer Center.

Under the terms of the Agreement, HDC will receive a 15 percent equity position in Smart Personalized Medicine based on up to a $5 million initial investment from Smart Personalized Medicine LLC investors. In addition, HDC will receive a per test royalty up to 7.5 percent based on net proceeds received from the sale of the new breast cancer prognostic test.

For more information; www.healthdiscoverycorp.com

Related Content

Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...